ImmunoCellular Therapeutics
| Region | Nordamerika |
| ISIN | US4525362046 |
| Sektor | Biotechnologie |
| Website | http://www.imuc.com/ |
ImmunoCellular Therapeutics, Ltd. , based in Los Angeles, is developing immune-based therapies for the treatment of cancer. ImmunoCellular is focused on advancing its Stem-to-T-Cell research program, which engineers hematopoietic stem cells to generate cytotoxic T cells.
| Titel | Datum |
|---|---|
| ABS Approves MISC and China Offshore's Ammonia FPSO Design | vor 18 Stunden |
| MISC Berhad and China Offshore secure ABS approval in principle for ammonia FPSO concept | vor 18 Stunden |
| MISC and China Offshore's ammonia FPSO design wins ABS' blessing | vor 19 Stunden |
| MISC, China Offshore Secure US Approval For Pioneering Ammonia FPSO Design | vor einem Tag |
| Stock Today: MISC Gains 0.41% Amid Offshore Contract Win | vor 7 Tagen |
| Diese Aktien könnten Dich auch interessieren | |
|---|---|
| Idea Fabrik (3 Artikel) | |
| Iconic Minerals (2 Artikel) | |
| Incyte (1 Artikel) | |
| India Globalization Capital (2 Artikel) | |
| Alle anzeigen | |